MYCN and neuroblastoma: Five patients were stratified into intermediate-risk group and 41 were categorized into high-risk group at initial diagnosis on the basis of the following factors: stage, age, International Neuroblastoma Pathologic Classification, amplification of the MYCN oncogene within tumor tissue.